Antipsychotic use in dementia has been linked to a variety of adverse outcomes, a recent study reveals. The research, published in The BMJ, highlights the increased risks faced by adults with dementia who use antipsychotic medications.
Dr. Pearl LH Mok and colleagues from the University of Manchester conducted a population-based matched cohort study focusing on adults aged 50 and older diagnosed with dementia between 1998 and 2018. The study found that antipsychotic use in this population was associated with a higher risk of several serious conditions, including stroke, myocardial infarction (MI), heart failure, venous thromboembolism (VTE), fracture, pneumonia, and acute kidney injury.
These findings underscore the importance of carefully considering the use of antipsychotic medications in individuals with dementia. While these drugs may be prescribed to manage certain symptoms, the potential risks must be weighed against the benefits to ensure the overall well-being of patients.
As research continues to shed light on the implications of antipsychotic use in dementia, healthcare providers and caregivers alike are encouraged to stay informed and work together to make informed decisions regarding treatment options for individuals with dementia.
